Three benzylpenicillin-resistant, clinical isolates of Enterococcus faecium (MIC values 16-64 yg ml-l) contained six penicillin-binding proteins (PBPs), of which PBPS was the most abundant and had the lowest affinity for the antibiotic. Four benzylpenicillin-susceptible strains (MIC values 0-031-0.5 pg ml-l) were obtained as spontaneous derivatives from these above organisms. There were significant decreases in the amounts of PBPS in each of the derivatives, with the concomitant appearance of a new, higher affinity PBP (5*) in three strains. Increased amounts of PBPS, with no changes in PBPS*, were found in several mutants with intermediatelevel benzylpenicillin-resistance (MIC values 1-8 pg mi-l) selected from two of the susceptible strains. Examination of 18 other clinical isolates, with a wide range of susceptibilities to benzylpenicillin (MIC values 0-062-128 pg ml-l), showed that PBP5* was present in 13 strains, and PBPS in all of them, but in differing amounts. The results concerning the relative amounts and relative affinities of PBPs 5* and 5 allowed the categorization of the various strains into six groups, within which organisms had somewhat similar susceptibilities to benzylpenicillin.
One or Two Low Affinity Penicillin-binding Proteins May Be Responsible for the Range of Susceptibility of Enterococcus faecium to Benzylpenicillin
Three benzylpenicillin-resistant, clinical isolates of Enterococcus faecium (MIC values 16-64 yg ml-l) contained six penicillin-binding proteins (PBPs), of which PBPS was the most abundant and had the lowest affinity for the antibiotic. Four benzylpenicillin-susceptible strains (MIC values 0-031-0.5 pg ml-l) were obtained as spontaneous derivatives from these above organisms. There were significant decreases in the amounts of PBPS in each of the derivatives, with the concomitant appearance of a new, higher affinity PBP (5*) in three strains. Increased amounts of PBPS, with no changes in PBPS*, were found in several mutants with intermediatelevel benzylpenicillin-resistance (MIC values 1-8 pg mi-l) selected from two of the susceptible strains. Examination of 18 other clinical isolates, with a wide range of susceptibilities to benzylpenicillin (MIC values 0-062-128 pg ml-l), showed that PBP5* was present in 13 strains, and PBPS in all of them, but in differing amounts. The results concerning the relative amounts and relative affinities of PBPs 5* and 5 allowed the categorization of the various strains into six groups, within which organisms had somewhat similar susceptibilities to benzylpenicillin.
I N T R O D U C T I O N
Most (70 %) clinical isolates of Enterococcus faecium are currently multiply resistant to a variety of antibiotics including P-lactam antibiotics, tetracycline, erythromycin and other macrolides, aminoglycosides (high level) and chloramphenicol (Horodniceanu & Delbos, 1980) . The natural resistance level of E. faecium to benzylpenicillin is assumed to be entirely due to the interactions of the antibiotic with the penicillin-binding proteins (PBPs) (Coyette et al., 1980) since P-lactamase activity has not been detected (Le Bouguknec & Horodniceanu, 1982; Weinstein & Moellering, 1975) and the cell wall does not act as a permeability barrier (Williamson et al., 1983) . In a study of two strains of E. faecium selected in vitro which had become extraordinarily susceptible to a variety of P-lactam antibiotics, Eliopoulos et al. (1982) showed that there were no apparent changes in the PBPs of these strains when compared with those of the wild-type, parental strains, Moreover, the susceptibilities of these strains to a variety of other antibiotics were generally the same as the parental strains. Previous results (Le Bouguhec & Horodniceanu, 1982) showed that resistance to tetracycline, erythromycin, aminoglycosides and chloramphenicol could be transferred by conjugation from E. faecium into E. faecalis, but that resistance to benzylpenicillin was not transferred. To extend these experiments, derivatives were obtained from three clinical isolates of E. faecium in which either single or multiple resistance characteristics were lost, either spontaneously or by treatment with ethidium bromide, in particular with a 32-to 2000-fold increase in susceptibility to benzylpenicillin. In the present studies we have examined the PBPs of these strains to determine the cause of the loss of this resistance. We also examined the PBPs in an additional 18 clinical isolates of E. faecium, which also had a 2000-fold range in susceptibilities to benzylpenicillin, with a variety of additional resistance patterns, to determine if the results obtained with the derivatives selected in vitro were applicable to the natural isolates.
METHODS
Bacterial strains andgrowth conditions. The 21 strains of E. faecium, identified by the criteria of Facklam (1972) , were from the collection of the Reference Centre of Streptococci, Institut Pasteur, Paris, France, and originally all were clinical isolates. Bacteria were grown without aeration at 37 "C in Brain-Heart Infusion broth (BHI; Difco), and growth was monitored with a Perkin-Elmer Junior I11 spectrophotometer at 650 nm.
Antibiotics and reagents. Benzylpenicillin and streptomycin were obtained from Specia, Paris, France, chloramphenicol and erythromycin from Roussel-Uclaf, Romainville, France, kanamycin from Bristol Laboratories, Paris, France, and tetracycline from Laboratoires Diamant, Puteaux, France.
[3H]Benzylpenicillin (26 Ci mmol-1 ; 0.66 TBq mmol-') was generously provided by RhBne-Poulenc Recherche, Vitry-sur-Seine, France, and synthesized at the Service des MolCcules Marqubes, Commissariat 2t 1'Energie Atomique, Gif-surYvette, France. Lysozyme was purchased from Sigma, and M1-muramidase was the generous gift of K. Yokogawa, Dainippon Pharmaceutical Co., Suita/Osaka, Japan.
Susceptibility tests. Minimum inhibitory concentration (MIC) values were determined using twofold dilutions of antibiotics in BHI agar. Approximately lo4 colony-forming units were applied to the agar surface with a Steers replicator. Plates were incubated for 18 h at 37 "C.
Isolation of antibiotic-susceptible and benzylpenicillin-resistant strains. Antibiotic-susceptible strains were obtained either spontaneously or by treatment of resistant strains with ethidium bromide at 42 "C as previously described (Horodniceanu et al., 1976) . Spontaneous, benzylpenicillin-resistant mutants were obtained by plating approximately l O9 exponential-phase organisms onto BHI agar containing benzylpenicillin at twofold increasing concentrations from the MIC up to 64 x MIC. Colonies were picked from plates up to the highest concentration of antibiotic allowing growth after 48 h incubation at 37 "C, and streaked onto BHI agar containing appropriate amounts of benzylpenicillin.
Analysis ofpenicillin-bindingproteins. The technique used was a modification of that used previously (Williamson et al., 1983) . Exponential-phase organisms (ODbSo of 0.25, approximately 2 x lo8 bacteria ml-I) were rapidly chilled in ice, centrifuged (5000 g for 2 min at 2 "C), resuspended in ice-cold 50 mM-sodium phosphate buffer, pH 7.0 (0.04 x original volume), and samples (40 pl) were incubated with various amounts of [3H]benzylpenicillin (04002-20 pg) in a final volume of 50 pl for 30 min at 37 "C. All PBPs were saturated within 15 min at the highest concentration of antibiotic. The samples were then placed in ice, an excess of unlabelled benzylpenicillin was added (2 ml of 1 mg ml-l), and the bacteria were recovered by further centrifugation as above. The supernates were removed by aspiration, and organisms were resuspended in 20 p1 sodium phosphate buffer containing 10 pg lysozyme, 10 pg M1-muramidase and 0.1 % (w/v) Triton X-100, and the samples were incubated at 37 "C for 20 min to cause complete lysis.
The PBPs in the lysates were analysed by SDS-PAGE and fluorography as previously described (Williamson et al., 1983) , except that the final concentrations of acrylamide and N,N'-bis-acrylamide in the separating gels were reduced to 6% (w/v) and 0.08% (w/v), respectively, to enable a significantly better resolution of the individual PBPs. Band densities of the PBPs on the fluorograms were quantified with a Helena Laboratories Cliniscan (Beaumont, Texas, USA) and were corrected for any variations in width. The data presented are the means of at least two experiments with each strain, and the variation was generally less than 7% of the mean.
RESULTS

Antibiotic susceptibilities and PBPs of parental and mutant strains
The antibiotic susceptibilities of the three wild-type clinical isolates and a variety of derivatives obtained from them are presented in Table 1 . Strains D359, D371 and D344 were resistant to benzylpenicillin (MIC values 16-64 pg ml-l), tetracycline (MIC values 64-256 pg ml-l), erythromycin (MIC values > 1024 pg ml-l) and to high levels of kanamycin (MIC values > 8000 pg ml-l) and streptomycin (MIC values > 2000 pg ml-l); strain D371 was also resistant to chloramphenicol (MIC 32 pg ml-l). Resistance to erythromycin, as well as to other macrolides and related antibiotics (MLS phenotype), was lost spontaneously from strain D359 to give BM6223. This strain and D344 were cured of aminoglycoside resistance by treatment with ethidium bromide to give strains BM6224 and BM6219, respectively. In contrast, strains BM6222 and BM622 1, obtained as spontaneous benzylpenicillin-susceptible derivatives from D371, had also lost resistance to all six antibiotics tested. Strains BM6225 and BM6218 were both obtained as spontaneous benzylpenicillin-susceptible derivatives from BM6224 and D344 respectively, but in the former case tetracycline resistance was also lost, whereas in the latter case there were no changes in resistance to the other four antibiotics. The spontaneous resistant mutants (BM6225/1, BM6225/2, BM6225/4, BM6221/0.5 and BM6221/4) selected with benzylpenicillin, at frequencies between lo-* and from strains BM6225 and BM6221 did not become resistant to other antibiotics.
The three resistant, clinical isolates D359 (Fig. I ), D371 and D344 (Fig. 1) had six PBPs, as did the erythromycin-or aminoglycoside-susceptible mutants (BM6223 and BM6224, and BM6219) isolated from D359 and D344, respectively. However, examination of the benzylpenicillin-susceptible mutants BM6225 (Fig. l) , BM6222 (Fig. 1) and BM6221 showed the presence of an extra band (PBP5*) and a significant reduction in the amount of PBP5, with a somewhat lower affinity in the two latter strains ( Table 1 ). In contrast, there was no PBP5* in strain BM6218 (Fig. 1) derived from D344, and in this case the reduced quantity of PBP5 had a much higher affinity for benzylpenicillin than the parental strain. Examination of the PBPs in the resistant mutants selected in uitro (BM6225/1, BM6225/2, BM6225/4, BM6221/0.5 and BM6221/4; Fig. 2, Table 1) showed that the amounts of PBPS were increased according to the (Fig. 2) . The amounts of PBPs 1,2,3 and 4 differed by up to threefold between the various strains (data not shown), but there was no correlation with the resistance level. Moreover, the affinities of these PBPs for benzylpenicillin did not differ significantly in the strains. The mean (with standard deviation) concentrations of [3H]benzylpenicillin required to give 50% saturation (S5, values) were (pg ml-l): PBP1,0.22 (0.04); PBP2,0*020 (0-007); PBP3,0.041 (0-021); and PBP4, 0.11 (0.032). The respective values for PBP6, measured in the three clinical isolates and the susceptible derivatives under conditions allowing resolution of this PBP, were 0.15 (0.049). Since all the PBPs had relatively high affinities for benzylpenicillin, and PBPS in the wild-type strains had Ss0 values in the range 0.5-1 x MIC, it seemed possible that PBP5 could be the essential PBP in these resistant organisms. In support of this, growth of the wild-type strains in nonradioactive benzylpenicillin at 0-2 x MIC for each strain resulted in almost complete saturation of PBPs 1 , 2 , 3 , 4 and 6, but only slight saturation of PBPS with no inhibition of the growth rate, suggesting that the other PBPs are non-essential targets. Subsequent experiments were done to examine whether PBP5* as well as PBPS existed in other wild-type strains.
Antibiotic susceptibilities and PBPs in clinical isolates
An additional 18 clinical isolates were chosen on the basis of a wide range of susceptibility to benzylpenicillin, the MIC values being from 0.062 to 128 pg ml-I, as shown in Table 2 which also includes the three wild-type, clinical isolates presented in Table 1 . Most of the relatively benzylpenicillin-susceptible strains (MIC values < 8 pg ml-I) were susceptible to the other antibiotics tested. In contrast, 10 of the 1 1 benzylpenicillin-resistant strains (MIC values > 8 pg ml-*) were multiply resistant.
PBPs 1 to 4 and 6 were found in all of the additional 18 strains in amounts and with affinities similar to those given earlier for strains D359, D371 and D344, except that in two strains (D360 and D368) the molecular weight of PBP2 differed slightly from that in other strains, and strain D66 had no PBP4. These differences could not be correlated with the resistance levels to benzylpenicillin. PBP5* was found in 13 of the 21 isolates (Table 2) , and this PBP was present mostly in the relatively benzylpenicillin-susceptible strains. The results concerning the amounts and affinities obtained with PBPs 5* and 5 allowed the grouping of the organisms into six categories (Table 2) , based primarily on the amounts of PBPS and the presence or absence of PBPS*. Strains within each group had somewhat similar susceptibilities to benzylpenicillin, as well as similar amounts and S,, values for PBPs 5* and 5. Two categories (3 and 5) did not contain PBPS*. When present, the amounts of PBP5* remained similar (with a twofold range) in the various strains, but the PBP had lower affinities for the antibiotic in the more resistant categories (4 and 6). In contrast, the amounts of PBPS differed significantly (Student's ?-test) between each of the six categories, and the mean values compared with that in category 1 were 3.6,9-4, 64,643 and 3.8 times greater in categories 2, 3,4, 5 and 6, respectively. The affinities of PBPS for benzylpenicillin in categories 3 and 4 appeared higher than those of PBPS in the other categories.
PBPs 5* and 5, or 5 alone if 5* was not present, were the most abundant PBPs in each strain, accounting for an average of 49% of the total under saturating conditions. The lowest amounts were found in strain D378 where PBPs 5* and 5 accounted for 37.5% of the total, and the greatest in strain D344 where PBPS accounted for 68.9% of the total PBPs.
When whole cells or membranes obtained from the various clinical isolates of E.faecium were incubated for extended periods (up to 150 min) under saturating conditions, there were no changes in the amounts of PBPs, and the results were identical to those obtained after 30 min.
DISCUSSION
In the present studies, the loss of resistance to benzylpenicillin in two strains of Enterococcus faecium was associated with a significant decrease in the amounts of a low affinity PBPS, and a new PBP5* not present in the parental strains was detected in most of the spontaneous, Table 2 , and show the relative amounts of PBPS* ( 0 ) and PBPS ( 0 ) adjacent to the septa1 wall. The total amounts of the PBPs are shown in proportion with that in category 1, and the area in which synthesis of peptidoglycan occurs for ingrowth of the septum is shaded. It is assumed that PBPs 5* and 5 outside this area are therefore not essential for this ingrowth. For the other categories of strains listed in Table 2 , PBPS*, when present, and PBPS would be included in the model in the amounts given. susceptible derivatives. These results differ greatly from those of Eliopoulos et al. (1982) , who found no changes in the PBPs of hypersusceptible derivatives of E. faecium, but this was probably due to insufficient saturation of PBPS in the wild-type strains. Analysis of PBPs in the various clinical isolates in our study revealed that most organisms (64%) contained both PBP5* and PBPS, and that six categories of strains could be defined on the basis of the amounts of PBP5, the presence or absence of PBPS*, and the affinity of PBP5* for benzylpenicillin. It would therefore seem likely that the natural susceptibility (or resistance) level of E. faecium to benzylpenicillin is related to the relative amounts as well as the relative affinities of two essential PBPs (5* and 5). Presumably, each of these proteins must have transpeptidase activity, and they must be the sole functional PBPs allowing continued growth of the organisms in concentrations of benzylpenicillin up to the minimal inhibitory concentration.
A possible mechanism is that PBPs 5* and 5 could be primarily located at the primary growth and division site (septum) of the cocci, that only a limited number of enzyme molecules can be involved in peptidoglycan synthesis in a small area of the nascent wall, and that the relative abundance of one enzyme compared with the other could determine which would have the major role in synthesis (Fig. 3) . For example, in category 1, PBPS* is present in double the amount of PBP5, which has the lower affinity. Therefore, when PBP5* becomes inhibited by benzylpenicillin, its function cannot be taken over by PBPS since the acylated PBPS* would physically block access of PBPS to the site of synthesis, or, alternatively, the low amount of PBPS is not enough for continued peptidoglycan synthesis. Thus the high susceptibility of strains in this category is due to the inhibition of the higher affinity target even though the lower affinity PBPS is present. Since the PBPs of E. faecium have extremely long half-lives when acylated with benzylpenicillin (Coyette et al., 1980; Williamson et al., 1983) it is unlikely that any great amounts of enzyme activity are regained by de-acylation of the complexes. Within category 2, the amount of PBPS is increased about three-to fourfold, and more of this PBP could be present at the growth site. In this situation, a large proportion of PBP5* could be saturated but the lower affinity target would still have sufficient activity to allow continued growth at a greater concentration of the antibiotic than that occurring in category 1. Categories 3 and 5 contain strains having only PBP5, therefore the resistance level is dependent only on the amount and affinity of this PBP.
On the basis of this above model, it would be expected that overproduction of the lower affinity target (PBP5) would decrease the susceptibility of the organism, since the increased amount could displace some of, or take over from, the higher affinity target (PBPS*) at the site of synthesis. In the present studies, spontaneous resistant mutants were obtained with up to an eightfold increase in the quantity of PBPS, but with unchanged amounts of PBPS*. Although the PBPs involved in resistance of enterococci to benzylpenicillin have been described as 'slowbinding PBPs' (Fontana et ai., 1983) , we would not define either PBPS* or PBPS as such, since this apparent characteristic is due to the extremely low affinity for the antibiotic and very high concentrations of [3H]benzylpenicillin can give relatively rapid saturation of these PBPs. (1982) were also deficient in membrane proteins with molecular weights of 82 kDal and 108 kDal, but neither of these corresponded to the molecular weights of the PBPs.
The basis for the appearance of PBPS* with partial loss of PBPS in some susceptible derivatives obtained from strains lacking PBPS* is unknown at present. It is interesting that these derivatives would be placed in category 1 of Table 2 on the basis of the amounts of PBPS, whereas both parental strains are in category 3. We speculate that E. faecium may be naturally relatively susceptible to benzylpenicillin, but that some mutation or other genetic change causes loss of PBPS* and overproduction of PBPS resulting in resistance to the antibiotic. Thus the organisms in categories 3 and 5 may have been derived from those in categories 1 and 2. Since the benzylpenicillin-resistant mutants selected in vitro only had increased amounts of PBPS, it seems possible that the loss of PBPS* and overproduction of PBPS may have been separate events during the evolution of resistance. Nevertheless, the benzylpenicillin-susceptible derivatives containing PBPS* were obtained spontaneously from three wild-type, resistant strains at a relatively high frequency therefore a single mutation or genetic change, different from that regulating only the amount of PBPS, may be responsible for the overall change. An alternative mechanism of resistance may be represented by the organisms in categories 4 and 6, in which the decreased affinities of PBPS* could be more important than the increased amounts of PBPS. Previous reports have shown that losses of PBPs and changes in affinities as well as amounts of PBPs, probably due to several different mutations, contribute to the resistance of some strains of Streptococcus pneumoniae to benzylpenicillin (Handwerger & Tomasz, 1984; Zighelboim & Tomasz, 1980) . We are currently investigating whether PBPs 5* and 5 have any biochemical homology. It seems unlikely that one is a degradation product of the other, since the continued incubation of whole cells or membranes with the radioactive benzylpenicillin did not change the amounts of either PBP.
Although the Occurrence of benzylpenicillin-suscepti ble derivatives was generally associated with loss of resistance to a variety of other antibiotics, the derivative BM6218 obtained from D344 retained the other resistance markers. The apparent reason for the susceptibility in this case was a fourfold decrease in the amount of PBPS together with a significant increase (about 35-fold) in the affinity of this PBP for benzylpenicillin, and we have recently found virtually identical results with one of the pairs of resistant (4379) and hypersusceptible (4379-S) strains obtained from G. M. Eliopoulos and R. C. Moellering, Jr (data not shown). Therefore, the strains BM6218 and 4379-S may have had mutations in the structural genes coding for PBPS, revealing a basis for susceptibility in addition to the appearance of PBPS* and partial loss of PBPS. Labischinski. Berlin: Walter de Gruyter.
